MedPath

Comparative Evaluation of Contact Lens Centering of DAILIES® AquaComfort Plus® Versus 1-DAY ACUVUE® MOIST® in Japan

Not Applicable
Completed
Conditions
Myopia
Myopic Astigmatism
Refractive Error
Interventions
Device: Nelfilcon A contact lenses
Device: Etafilcon A contact lenses
Registration Number
NCT02103309
Lead Sponsor
Alcon Research
Brief Summary

The purpose of this study is to evaluate lens centration and subjective impressions of DAILIES® AquaComfort Plus® (DACP) lenses compared to 1-DAY ACUVUE® MOIST® (1DAM) lenses in ball sports players.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
42
Inclusion Criteria
  • Those who can understand the clinical study objectives and provide written informed consent. Legal representative or parental consent required if under age 20
  • Those who regularly wear soft contact lenses in both eyes for a minimum of 8 hours per day and 5 days per week
  • Those who play ball sports at least 1 day per week
  • Those who need vision correction because of myopia or mild myopic astigmatism, who are eligible for use of the study device, and who can attain a visual acuity of at least 1.0 with correction
  • Other protocol-defined inclusion criteria may apply
Exclusion Criteria
  • Those who regularly wear the study device
  • Those who require ocular treatment with eye drops
  • Those who have a condition contraindicating soft contact lens wear, such as eye irritation
  • Those who have had ocular disorder or ocular surgery that may affect soft contact lens wear within 3 months before the start of the study
  • Those who are participating in another clinical study or research or have a plan of such participation during the present study
  • Women who are pregnant or intend to become pregnant during the study
  • Other protocol-defined exclusion criteria may apply

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
1DAM, then DACPEtafilcon A contact lensesEtafilcon A contact lenses worn first, then nelfilcon A contact lenses worn second. Each product worn bilaterally (in both eyes) for 1 week in a daily disposable mode.
1DAM, then DACPNelfilcon A contact lensesEtafilcon A contact lenses worn first, then nelfilcon A contact lenses worn second. Each product worn bilaterally (in both eyes) for 1 week in a daily disposable mode.
DACP, then 1DAMEtafilcon A contact lensesNelfilcon A contact lenses worn first, then etafilcon A contact lenses worn second. Each product worn bilaterally (in both eyes) for 1 week in a daily disposable mode.
DACP, then 1DAMNelfilcon A contact lensesNelfilcon A contact lenses worn first, then etafilcon A contact lenses worn second. Each product worn bilaterally (in both eyes) for 1 week in a daily disposable mode.
Primary Outcome Measures
NameTimeMethod
Mean Investigator-Rated Lens CentrationAfter 1 week of wear

Lens centration was assessed by the investigator using slit-lamp microscopy and rated on a 5-point scale, where 0=Optimal and 4=Severe decentration. Both eyes contributed to the mean.

Secondary Outcome Measures
NameTimeMethod
Average Subjective Ratings Score (Lens Handling and Overall Vision)After 1 week of wear

The participant rated the handling and overall vision of the contact lenses on a 10-point scale, where 10=Excellent and 1=Poor. Both eyes contributed to the mean.

Mean Investigator-Rated Lens FitAfter 1 week of wear

Lens fit was assessed by the investigator and rated on a 5-point scale with -2=Unacceptable tight fit, -1=Acceptable tight fit, 0=Optimal, 1=Acceptable loose fit, and 2=Uacceptable loose fit. Both eyes contributed to the mean.

Average Subjective Ratings Score (Lens Wearing Conditions and Visual Performance During Ball Sports)After 1 week of wear

The participant rated the lens wearing conditions and visual performance of the contact lenses during ball sports on a 10-point scale, where 10=Agree and 1=Disagree. "Overall Vision" was rated with 10=Excellent and 1=Poor. Both eyes contributed to the mean.

© Copyright 2025. All Rights Reserved by MedPath